Abstract
Objective: The Lee-Jones model posits that antecedent individual and interpersonal factors predicate the development of fear of cancer recurrence (FCR) through cognitive and emotional processing, which further to behavioral, emotional, and/or physiological responses. We analyzed data from FoRtitude, a FCR intervention grounded in the Lee-Jones FCR model, to evaluate associations between FCR antecedents, resources (e.g., breast cancer self-efficacy, BCSE) and psychological and behavioral consequences. Methods: Women with breast cancer who completed treatment and reported clinically elevated levels of FCR were randomized into a 4-week online psychosocial intervention or contact control group. We assessed BCSE, FCR, and physical activity, anxiety and depression, or symptoms at baseline, 4 and 8 weeks. Separate structural equation models were constructed with both baseline data and change scores (baseline-8 weeks) to examine the pathways linking BCSE, FCR and: (1) physical activity; (2) anxiety and depression; and (3) symptoms (fatigue, sleep disturbance, cognitive concerns). Results: At baseline, higher levels of BCSE were associated with lower levels of FCR. Higher FCR was associated with worse psychological effects and symptoms but not behavioral response. Change models revealed that an increase in BCSE was associated with a decrease in FCR at 8-week assessment, which was associated with reductions in psychological effects. A change in BCSE was also directly associated with reductions in psychological effects. Conclusions: Results support the Lee-Jones model as a foundation for FCR interventions among breast cancer survivors. Replicability among varied populations is needed to examine effects on behavioral outcomes of FCR such as health care utilization. Clinical Trials Registration: NCT03384992.
Original language | English (US) |
---|---|
Pages (from-to) | 256-265 |
Number of pages | 10 |
Journal | Psycho-oncology |
Volume | 32 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2023 |
Funding
This project was funded by the National Cancer Institute (1R21 CA173193), 1UG1CA189828, the ECOG‐ACRIN Medical Research Foundation and was partly supported by a National Cancer Institute training grant (R25 CA122061). We thank the breast cancer survivors who participated in this study. We thank study investigators, nurses, clinicians and study personnel at Aurora, Metro Minnesota, and Colorado Cancer Research Program NCORP Sites and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University for support with trial recruitment. This project was funded by the National Cancer Institute (1R21 CA173193), 1UG1CA189828, the ECOG-ACRIN Medical Research Foundation and was partly supported by a National Cancer Institute training grant (R25 CA122061). We thank the breast cancer survivors who participated in this study. We thank study investigators, nurses, clinicians and study personnel at Aurora, Metro Minnesota, and Colorado Cancer Research Program NCORP Sites and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University for support with trial recruitment.
Keywords
- breast cancer
- fear of recurrence
- oncology
- patient-reported outcomes
- quality of life
- self-efficacy
- survivorship
ASJC Scopus subject areas
- Experimental and Cognitive Psychology
- Psychiatry and Mental health
- Oncology